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ABSTRACT: Bone metabolism is affected by mechanical, genetic, and environmental factors and plays a
major role in osteoporosis. Nevertheless, the influence of environmental pollution on the occurrence of
osteoporosis is still unclear and controversial. In this context, heavy metals are the most important pollu-
tants capable to affect bone mass. The aim of this study was to investigate whether heavy metals accu-
mulation in bone tissues could be related to the altered bone metabolism and architecture of
osteoporotic patients. To this end, we analyzed 25 bone head biopsies osteoporotic patients and 25 bone
head biopsies of osteoarthritic patients. Moreover we enrolled 15 patients underwent hip arthroplasty for
high-energy hip fracture or osteonecrosis of the femoral head as a control group. Bone head biopsies
were studied by BioQuant-osteo software, scanning electron microscopy and Energy Dispersive X-ray
microanalysis. We found a prevalence of lead, cadmium and chromium accumulation in osteoporotic
patients. Noteworthy, high levels of sclerostin, detected by immunohistochemistry, correlate with the
accumulation of heavy metal found in the bone of osteoporotic patients, suggesting a molecular link
between heavy metal accumulation and bone metabolism impairment. In conclusion, the presence of
heavy metals into bone shed new light on the comprehension of the pathogenesis of osteoporosis since
these elements could play a non redundant role in the development of osteoporosis at cellular/molecular
and epigenetic level. Nevertheless, in vivo and in vitro studies need to better elucidate the molecular
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INTRODUCTION
Osteoporosis is the most common metabolic bone disease,
characterized by a decrease of bone mass and a degenerative
change of bone microstructure, resulting in an increased risk
of fracture (Cerocchi et al., 2013). A rapidly expanding
amount of evidence indicates that osteoporosis is likely to be
caused by complex interactions between local and systemic
regulators of bone cell function. Indeed, osteoporosis results
in a dysfunction of physiological bone turnover where endo-
crine and/or autocrine/paracrine factors negatively affect
peak bone mass and/or skeletal homeostasis (Drake et al.,
2015, O’Flaherty, 2000). Patients with osteoporosis show a
higher propensity to spine, femur and fractures. Osteoporotic
fracture caused by a minor injury often occurs in cancellous
bone-rich zone, with increasing disability and lethality rates,
which may seriously affect the quality of life of older per-
sons (Andreoli et al., 2011).
Several studies, revealed that heavy metals exposure may
affect bone mass (James and Meliker, 2013; Sadeghi et al.,
2014; Tsai et al., 2015). In particular, lead (Pb) is associated
to bone mass deficiency and osteoporotic condition. Pb
accumulates in bones already during fetal development, and
adverse effects on bone metabolism present even after low
level of exposure (Berglund et al., 2000; Khalil et al., 2008).
It causes growth retardation by inhibiting endochondral ossi-
fication. Increased bone turnover and reduced mineralization
combine to decrease bone mineral density and mass, and, in
the most severe cases, cause osteoporosis (Dermience et al.,
2015). Other important heavy metals that influence bone
metabolism are cadmium (Cd), copper (Cu), chromium (Cr),
and cobalt (Co). In vitro studies demonstrated toxic effects
of Cd and Cr on bone cells. In particular, ions form of these
elements affects osteoblast proliferation, size, and shape
(Bhattacharyya, 2009; Soudani et al., 2011). Moreover, Cd
and Cr are able to influence osteoblastic activity by decreas-
ing alkaline phosphatase levels and calcium accretion (Der-
mience et al., 2015). Co is an essential trace element since it
is the core component of vitamin B12. Several in vitro stud-
ies revealed that Co influences bone resorption and bone for-
mation by modulating bone cell metabolism (Dermience
et al., 2015). Moreover, Fleury et al. demonstrated that Co
accumulation increases oxidative stress in bone tissues
(Fleury et al., 2006). These effects could be mediated by the
redox state in osteoblast-like cells, but the mechanism of
action is not known (Fleury et al., 2006). However, studies
were mainly performed in vitro or in human serum and rare-
ly on bone by ultrastructure analysis. Therefore, the aim of
this study was to investigate whether heavy metals
accumulation in bone tissues, i.e. Pb, Cd, Co, and Cr, could
be related to the altered bone metabolism and architecture of
osteoporotic patients.
MATERIAL END METHODS
Patients
In this retrospective study, we enrolled 25 patients that
underwent hip arthroplasty for medial femoral fracture (OP)
(18 women and 7 men; age 77.806 1.94) and 25 patients
underwent hip arthroplasty for osteoarthritis (15 women and
10 men; age 73.806 1.24) in the Orthopedic Department of
“Tor Vergata” University. Moreover we enrolled 15 patients
(7 women and 8 men; age 46.196 2.78) underwent hip
arthroplasty for high-energy hip fracture of the femoral head
as a control group. All patients enrolled in the study lived in
the metropolitan area of Rome, Italy for at least 30 years.
Exclusion criteria were history of neoplastic diseases,
myopathies or other neuromuscular diseases or chronic
administration of corticosteroid for autoimmune diseases
(more than 1 month), diabetes, alcohol abuse, viral chronic
infections (HBV, HCV, HIV), previously orthopedic surgi-
cal implants.
Bone Mineral Density Evaluation
Bone mineral density evaluation (DXA) was performed with
a Lunar DXA apparatus (GE Healthcare, Madison, WI).
Lumbar spine (L1–L4) and femoral (neck and total) scans
were performed, and bone mineral density (BMD) was ana-
lyzed according to manufacture recommendations (Celi
et al., 2013). Dual-energy X-ray absorptiometry measures
BMD (in grams per square centimeter) with a coefficient of
variation of 0.7%. For patients with cervical femoral fragili-
ty fracture, BMD was measured on the limb opposite to the
fracture side. Conversely, for the other patients all measure-
ments were performed on the nondominant side, while par-
ticipants lay supine on an examination table with their limbs
abducted away from the trunk (Piccirilli et al., 2014). DXA
exam was performed 1 day before surgery for OA patients
and 1 month after surgery for hip fracture patients. Results
were expressed as T scores values.
Radiographic Analysis
Hip radiographs of all patients were obtained using a stan-
dard, validated protocol (Kothari et al., 2004). Two ortho-
pedists independently, and at different time, assessed all
radiographs using the Kellgren–Lawrence (K2L)
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radiographic atlas (Kellgren and Lawrence, 1957). Disagree-
ments between the two orthopedists were resolved by con-
sulting a third orthopedist. If at least one hip joint was
graded as K–L 2, the participant was diagnosed with
radiographic hip osteoarthritis.
Hematochemical Exam
During hospitalization, we collected blood samples by both
OP and OA patients.
Samples (n5 50) were investigated for serum concentra-
tions assay of creatinine, azotemia (BUN), phosphorus, cal-
cium, Vit D (25OHD3) and intact PTH.
Sampling
During open surgery of hip arthroplasty, we took the femoral
head to obtain a bioptic sample (Fig. 1). For bioptic proce-
dure, we excluded macroscopic alteration of trabecular bone
as necrosis areas. All sampling and experiments were per-
formed in agreement with independent ethical committee of
“Policlinico Tor Vergata” (approval reference number # 85/
12), and Informed consent was obtained from all individual
participants included in the study.
Histology and Histomorphometric Analysis
Bone head samples were fixed in 4% paraformaldehyde for
24 h and paraffin embedded without decalcification process.
From each patient, we obtained two paraffin blocks. Finally,
3-mm-thick sections were cut with tungsten carbide knife
and stained with hematoxylin and eosin (H & E).
For each bioptic sample of OP and OA patients, we eval-
uated at least 10 microscopic images randomly selected
from at least two bone slides for patient. Images were
acquire at 403 magnification by using a Nikon Eclipse
E600light microscope connected to a Nikon digital camera
and saved at a resolution of 12803 1024 pixels. Successive-
ly, the images were analyzed by using a BioQuant Osteo
software (version7.20.10; BIOQUANT Image Analysis Cor-
poration, Nashville, USA) according to the manufacture’s
suggestions (Tarantino et al., 2014). From the BioQuant
Osteo analysis we evaluated the following parameters: bone
volume (BV/TV), trabecular thickness (Tb.Th) and trabecu-
lar separation (Tb.Sp).
Fig. 1. Bone head sampling. (A) During open surgery of hip arthroplasty, we took the femoral head to obtain a bioptic sample.
Subchondral bone columns of 0.8 cm in diameter and 3 cm in length were extracted from the loading area of the femoral
head. (B, C) Two columns obtained by cutline “M” were fixed in formalin 4% and embedded in paraffin for histological and
immunohistochemical analysis. (D, E) From two columns obtained by cutline “S” we dissected 0.8 cm in diameter and 1 cm
in length of bone trabecular tissue distant 0.2 cm to cartilage for SEM-EDX studies. [Color figure can be viewed in the online
issue, which is available at wileyonlinelibrary.com.]
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Washings were performed with PBS/Tween20 pH 7.6
(UCS diagnostic, Rome, Italy); reactions were revealed by
HRP–DAB Detection Kit (UCS diagnostic, Rome, Italy).
Scanning Electron Microscopy (SEM)
One cm in diameter and 1 cm in length of bone trabecular
biopsies, distant 0.2 cm to cartilage (Fig. 1), were fixed in
4% (v/v) paraformaldehyde for 24 h. After washing with
0.1 M phosphate buffer, the sample was dehydrated by a
series of incubations in 30, 50, and 70% (v/v) ethanol. Dehy-
dration was continued by incubation steps in 95% (v/v) etha-
nol, absolute ethanol and acetone. Critical point drying
(Agar Scientific, Essex, UK, Elektron Technology UK,
Cambridge, UK) with supercritical CO2 was then performed
to prevent cell deformation (Carpentieri et al., 2015). A
SEM LEO 1450VP (Carl Zeiss Meditec, Oberkochen, Ger-
many) was employed to acquire backscattered electron
images using 20 keV electrons leading to an information
depth of about 1.5 lm. Images with a scan size of 30 3 30
lm2 were acquired, at a resolution of 10243 1024 pixels.
EDX Microanalysis
In recent studies, we applied EDX assay to human biopsies
to study both the elemental composition of tissue and heavy
metals associated to lung cancers (Scimeca et al. 2014a,b;
Scimeca et al., 2016a).
The EDX microanalysis performs the chemical analysis
of a sample describing the elemental composition of a tissue
utilizing electron microscopy techniques. When the electron
beam in an electron microscope hits a thin sample, some
atoms of the sample will be excited or ionized. When they
return into their ground state, they will emit characteristic X-
rays (Scimeca et al., 2016b). The X-ray emission at different
wavelengths may then be measured by a photon-energy-
sensitive detector. EDX microanalysis was performed on
unpost-fixed and uncoated bone biopsies were placed on spe-
cific stub using a liquid N2-cooled Si detector with a super-
ultrathin Be window. Spectra were collected by a SEM LEO
1450VP scanning electron microscope at acceleration volt-
age of 5 KeV employing an area scan mode (640 3 640
lm2 sampling area), 300 s acquisition time, and 32–37%
detector dead time. Analysis of acquired spectra was per-
formed under a nonstandard mode using atomic number–
absorption–florescence correction (ZAF) methods using Inca
Energy software (Oxford Instruments, High Wycombe, UK;
Si(Li) detector, ATW—atmospheric thin window, resolution
133 eV for Mn Ka at 10,000 counts). For each specimen, we
acquire five spectrum on 8 mm2 of bone surface in total.
Results were expressed as presence or absence of metals.
Immunohistochemistry
Immunohistochemical characterization was performed to
assess sclerostin expression in all femoral head biopsies.
Briefly, 3-lm-thick sections were pre-treated with EDTA
citrate pH 7.8 for 30 min at 958C and then incubated with
mouse monoclonal Anti-sclerostin antibody for 60 min
(1:100, clone MY-32, AbCam).
Statistical Analysis
Descriptive statistics was used to summarize pertinent study
information. Categorical variables were reported as frequen-
cies and percentage values, whereas continuous variables
were summarized by mean values and their relative standard
deviations. Correlations between categorical variables were
evaluated through non-parametric tests, such as the Pear-
son’s Chi-Square test or the Fisher exact test, when appropri-
ate. P values< 0.05 denote statistically significant
correlations. Statistical analyses were carried out using the
SPSS software (SPSS ver. 21.0, SPSS, Chicago, IL). Clinical
and Immunohistochemical data were analyzed by Mann–
Whitney test (p< 0.0005) using Graph Pad Prism 5 Software
(La Jolla, CA).
RESULTS
Histomorphometrical Analysis
The BioQuant Osteo software allowed us to analyze the
bone quality parameters such as bone volume (BV/TV), tra-
becular thickness (Tb.Th), and trabecular separations (Tb.S)
[Fig. 2(A–C)]. As regards to BV/TV, we observed a signifi-
cantly higher mean value in OA patients respect to OP group
(OA 0.2516 0.018 vs. OP 0.1136 0.008 mm2) [Fig. 2(A)].
Noteworthy, dispersive graph shows that OA group was
characterized by very heterogeneous BV/TV values. Indeed,
in this group we observed patients with both high value of
BV/TV and levels of BV/TV compatible with OP condition.
However, our data indicated that in OA group low BV/TV
values were associated with older patients. Tb.Th values
were significantly higher in OA respect to OP groups (OA
0.2426 0.084 mm vs. OP 0.1126 0.027 mm) [Fig. 2(B)]. In
OP patients, Tb.Th values were very low and only six
patients were characterized by values similar to those of OA
group. Conversely, we note a homogenous distribution of
Tb.Th values in OA. As concern Tb.S values OP patients
showed higher values respect to OA [Fig. 2(C)] (OA
0.4996 0.115 mm; OP 1.0806 0.269 mm).
Heavy Metals Detection
In this study we set up an ultrastructural microanalysis assay
in order to characterize the presence of Pb, Cr, Cd, and Co
in head femoral biopsies [Fig. 2(D–F)]. Differences between
OP and CTRL and OA groups were statistically significant
in terms of Pb, Cr, and Cd accumulation in bone (Fig. 3).
Considering the individual elements, Pb was detected in
92% of OP samples, whereas Cr and Cd were present in
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Fig. 2. Evaluation of bone morphometric parameters and SEM-EDX microanalysis. The
BioQuant Osteo software allowed us to analyze the bone quality parameters such as Bone
Volume (BV/TV), trabecular thickness (Tb.Th) and trabecular separations (Tb.S) of OP and
OA patients (A–C). (A) Graph show a significantly higher mean value of BV/TV in OA
patients respect to OP group. (B) In OP patients, Tb.Th values were very low and only six
patients were characterized by values similar to those of OA group. Conversely, we note a
homogenous distribution of Tb.Th values in OA. (C) Tb.S values were significantly higher in
OP patients compare to OA. Morphological analysis and heavy metal detection (D–F). (D)
CTRL patients were characterized by a conserved trabecular net (H & E 32; electron
micrograph 360). (E) Bone head biopsies of OA patients display moderate trabecular thin-
ning and decrease of transversal trabeculae (arrows) (H & E 32; electron micrograph 360).
(F) OP patients showed a remarkable loss of both trabecular thickness and number of
transversal trabeculae (H & E32; electron micrograph 360). Bone marrows was frequently
substituted by fat (asterisks). [Color figure can be viewed in the online issue, which is avail-
able at wileyonlinelibrary.com.]
60% and 32%, respectively (Fig. 3). Conversely, we did not
found differences in the accumulation of Co (OP 32%; OA,
28%; CTRL 7%) (Fig. 3). A high rate of OP femoral head
biopsies showed the co-presence of more than one bio-
accumulated element (Fig. 3). Interestingly, we could find
significant differences (P< 0.0001) among the groups, when
we compared the bio-accumulation of two or more elements.
In particular, at least two elements were present in 80% of
OP, 44% of OA, and 7% CTRL, whereas more than three
elements were found in 48% of OP and 4% OA (Fig. 3). The
frequency of accumulation of toxic elements in CTRL group
was less and the presence of two elements was only occa-
sionally reported (at least two elements 7%; at least three
elements 0%) (Fig. 3).
Immunohistochemistry
Sclerostin analysis was performed by immunohistochemistry
and the levels of its expression were quantified by assigning
a score from 1 to 3 according to the intensity of positive sig-
nals in osteocyte cells. As aspect, we observed a significantly
higher signal of sclerostin in OP group respect to both
CTRL and OA patients (OP 2.286 0.15; OA 1.326 0.13;
CTRL 0.926 0.08) (fig.4). We also compared the expression
of sclerostin between OP patients with at least three heavy
metal elements and OP patients with less than three ele-
ments. Our data showed a significant rise of sclerostin
expression in patients with at least three elements [Fig.
4(H)]. Surprisingly, only in OP patients, sclerostin was
expressed by bone marrow adipocytes too.
Clinical Evaluation
Clinical and instrumental evaluation allowed us to character-
ize patients enrolled in this study. OP group included 25
patients with fragility hip fracture, T score 22.5 SD and
K–L score from 0 to 1; whereas OA group included 25
patients with positive radiogram for hip OA with a K–L
Fig. 3. Heavy metals accumulation in osteoporotic patients. Percentage distributions of the four heavy metals according to
the three group of tissues: (A) lead (Pb); (B): chromium (Cr); (C): cadmium (Cd); (D): cobalt (Co). The presence of heavy metals
revealed respectively in OP, OA and CTRL were reported as percentage. *Chi-Square’s test. P values refer to comparisons
between the two groups of tissues according to the presence of each specific element.
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score 3 or 4 and T score 22.5 SD. Moreover, OA and OP
patients displayed homogenous values of mainly hemato-
chemical exams of both bone and kidney metabolism (Table
I). Finally, for CTRL patients we assume T score 22.5 SD
and K–L score from 0 to 1.
DISCUSSION
The skeleton is a metabolically active organ since mechani-
cal, genetic and environmental factors affect bone metabo-
lisms that undergoe continuous remodeling throughout life.
Nevertheless, the role of environmental pollution on bone
metabolism is still unclear and controversial. Exposure to
heavy metals, the most important pollutants capable to affect
bone mass (Berglund et al., 2000; Sadeghi et al. 2014; Zheng
et al., 2014; Tsai et al., 2015 ) continues even though several
adverse health effects have been known and international
associations such as the WHO (WHO, 1992, 1995) monitor
them regularly. The main threats to human health from
heavy metals are associated with Pb, Cd, Co, and Cr
exposure.
To investigate the influence of Pb, Cr, Cd, and Co on a
metabolic disorder of the bone disease such as osteoporosis,
we analyzed 25 bone biopsies of OP patients with femur fra-
gility fracture by SEM-EDX microanalysis to evaluate their
Fig. 4. Expression of sclerostin in bone head biopsies. (A) H & E section showed a bone tissue of CTRL group with a con-
served trabecular net and remodeling area (asterisk) (34). (B) Image displayed no/low expression of sclerostin in a CTRL
patient. (C) H & E section of OA bone tissues (34). Bone biopsies are characterize by compact trabeculae. (D) Immunohisto-
chemical analysis show a lower/moderate expression of sclerostin by osteocytes (arrows) (310). (E) H & E section show a
bone tissue of OP patients (34). Trabeculae were thinned and bone marrows was frequently substituted by fat (asterisks) (F)
Immunohistochemical reaction display high sclerostin expression by osteocyte cells (arrows) (310). (G) Graph showed a sig-
nificantly higher signal of sclerostin in OP group respect to both OA and CTRL patients. (H) Graph displayed a significant rise
of sclerostin expression in OP patients with at least three elements respect to OP patients with less than three elements. [Col-
or figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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elemental composition. In addition, we enrolled OA patients
to compare heavy metal accumulation in patients with simi-
lar age range. As control group, we studied bone femoral
head biopsies of patients with high-energy fracture or osteo-
necrosis (CTRL).
Bone morphometric analysis showed a reduction of both
BV/TV and Tb.Th in OP patients. Moreover, in this group,
bone remodeling was often missing (data not shown). Never-
theless, evaluating the distribution of bone quality values,
we noted that some OP patients showed bone quality compa-
rable to OA group. The evaluation of bone morphology
allowed us to demonstrate that cells involved in bone remod-
eling (osteoblasts, osteoclasts, and osteocytes) were often
rare or absent in bone head trabecular tissues of OP patients.
Several studies demonstrated the epidemiological correla-
tion between environmental pollution and occurrence of OP
(Kung and Huang, 2007; Ongphiphadhanakul, 2007). How-
ever, to the best of our knowledge, any study has been per-
formed about heavy metals accumulation into bone tissue at
the ultrastructural and microanalytical level.
Thanks to the SEM-EDX microanalysis we demonstrated
a specific accumulation of heavy metals in trabecular bone
tissue. Toxic elements bio-accumulation appears a time
dependent phenomenon, as demonstrated by the low pres-
ence of metals in under 50 patients (CTRL). Indeed, we
demonstrated that trabecular tissues of OP patients harbor a
higher number heavy metals (i.e., Pb, Cr, and Cd) than
patients with comparable age (OA). It should be noted that
the heavy metals we detected coincide with those emitted in
the atmosphere by natural and/or anthropic sources (Bell
et al., 2009; Srimuruganandam and Nagendra, 2011).
The most frequent element in bone of OP group was Pb.
In vitro experiments demonstrated the ability of Pb to inhibit
osteoblast differentiation and activity (Dermience et al.,
2015). In particular, it affects hormonal secretion and
hormonal-induced cell responses, particularly to 1,a25-dihy-
droxycholecalciferol and IGF-1, inhibits bone-related protein
synthesis, including osteocalcin, collagen and osteopontin,
and suppresses Wnt signaling (Angle et al., 1990, Sauk
et al., 1992). The possible inhibition of osteoblast exerted by
Pb, allowed us to explain the inverse correlation between Pb
accumulation and bone quality observed in our samples.
Indeed, we frequently detected Pb in bone tissues of OP
patients with lower values of BV/TV (data not shown).
Noteworthy, the presence of Pb was observed also in 52% of
OA patients and in 20% of CTRLs. For long time the nega-
tive effect of Cd on bone mass was attributed to its capability
to cause renal tubular dysfunction (Schutte et al., 2008).
However, recent studies highlighted the direct role of cadmi-
um on bone metabolisms (Yokota and Tonami, 2008). The
direct pathway implicated in cadmium bone toxicity could
be linked to calcium homeostasis and bone cell metabolism.
Because of similar properties, Cd can impair calcium metab-
olism during osteogenesis and bone homeostasis by increas-
ing calciuria and altering calciotropic hormones (Dermience
et al., 2015). In this context, our data support the hypothesis
of a direct role of Cd in bone metabolism. Indeed, as for Pb,
we displayed Cd accumulation in patients with lower bone
quality parameters. Moreover, tissues with both Pb and Cd
accumulation were characterized by both poor bone quality
and reduction/absence of osteoblasts. Cr intoxication from
environmental exposure is not common, except in
chromium-related industries and associated environments
(Soudani et al., 2011). Reduced bone formation may be
mediated via cytotoxic effects of Cr on osteoblasts, which
reduce proliferation, inhibit osteocalcin release, and decrease
alkaline phosphatase activity. These effects are associated
with oxidative stress, which can be caused by unbalanced
OPG/RANKL ratios and dysregulation of antioxidant
enzyme expression (Anderson et al., 1997). Our data showed
that the accumulation of Cr into bone structure was less fre-
quent respect to Pb. However, in some OP samples we iden-
tified simultaneous presence of Pb, Cd, and Cr. Noteworthy,
in the context of OP group we found a significantly
TABLE I. Main anamnestic and instrumental data of OP, OA, and CTRL patients
OP OA CTRL
T Test
(Mann–Whitney Test)
Age 77.806 1.94 73.326 1.24 46.196 2.78 OP vs OA ns (P5 0.13; OP vs
CTRL *** (P< 0.001); OA vs
CTRL *** (P< 0.001)
BMI 22.586 1,50 28.066 0.80 / *** (P5 0.0005)
T Score (L1-L4) 22.86 0.17 0.456 0.5 / *** (P5 0.0005)
T Score (neck) 22.76 0.28 20,376 0.33 / *** (P5 0.0005)
Creatinine (BUN) (mg dL21) 0.976 0.10 1.56 0.34 / ns (P5 0.15)
Azotemia (mg dL21) 48.806 4.7 49.66 6.00 / ns (P5 0.60)
Phosphorus (mg dL21) 2.926 0.08 3.526 0.21 / ** (P5 0.0083)
Calcium (mg dL21) 8.456 0.12 8.606 0.11 / ns (P5 0.29)
Vit D(25OHD3) (ng mL21) 10.266 2.60 21.636 9.00 / ns (P5 0.47)
PTH (pg mL21) 135.106 41.00 81.006 10.00 / ns (P5 0.62)
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difference between t score values of patients with at least
three elements (Pb included) and t score values of patients
with less than three elements. In particular, OP patients with
at least three elements showed a low BMD. Moreover, these
patients showed low values of main morphological parame-
ters such as BV/TV and Tb.Th (data not shown). In the
human, the inverse relationship between heavy metals (Pb
and Cd) and BMD values were already described (Khalil
et al., 2008; Callan et al., 2015; Rzymski et al., 2015;
Garcıa-Esquinas et al., 2015). Nevertheless, in these studies
heavy metals were found in blood but not into bone struc-
ture. Therefore, the ability of heavy metals to affect BMD
could be just speculate. Indeed, the accumulation of heavy
metals in the blood can indirectly influence bone metabolism
affecting renal function and/or female reproductive system
(Rzymski et al., 2015).
To correlate heavy metal accumulation with bone metab-
olism, we studied the expression of sclerostin, a protein with
anti-anabolic effects on bone formation (Yavropoulou et al.,
2014). High levels of sclerostin revealed in tissues with Pb,
Cd, and Cr, candidate it as a molecular link between heavy
metals accumulation and bone metabolism impairment.
Indeed, sclerostin expression was higher in tissues with at
least two heavy metals accumulated.
Summing up, our data highlighted the importance of Pb,
Cd, and Cr in bone health. The presence of these elements is
convincingly connected to the environmental pollution, as
assessed by habitat conditions of the investigated patients.
Indeed, they live in a large urban center in which heavy met-
als concentration is often upper safety threshold values.
However, the possible sources of heavy metals, such as con-
taminated water and food, dental implant, etc., are numerous
and difficult to identify.
CONCLUSION
The identification of heavy metals into bone structure opens
new perspectives about the pathogenesis of osteoporosis. In
addition, from clinical point of view, the detection of heavy
metals contamination into the bone or other tissues (i.e.,
blood) could become a powerful tool to assessing bone sta-
tus. To better elucidate the molecular mechanism in which
heavy metals can participate to osteoporosis development in
humans, in vivo and in vitro studies are needed. Furthermore,
it would be interesting to validate the results of present study
in a larger cohort of patients correlating SEM-EDX data
with serum concentration of heavy metals. In fact, heavy
metals, such as Pb, Cr, and Cd, could contribute to develop-
ment of osteoporosis at both cellular/molecular and epige-
netic level.
It was very important to take advantage of the funds made
available by the ASI because it encourages our present and further
research within the project titled “Multidisciplinary Study of the
Effects of Microgravity on Bone Cells” call number search DC-
DTE-2011-033.
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